Acetylcysteine Injection, Solution
Product Images NDC 55150-259

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 55150-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Rumack-matthew Nomogram For Estimating Potential For Hepatotoxicity For Acetaminophen Posioning – Plasma Or Serum Acetaminophen Concentration Versus Time (hours) Post-acetaminophen Ingestion (Acetylcysteine Fig1)

Figure 1. Rumack-matthew Nomogram For Estimating Potential For Hepatotoxicity For Acetaminophen Posioning – Plasma Or Serum Acetaminophen Concentration Versus Time (hours) Post-acetaminophen Ingestion (Acetylcysteine Fig1)
This appears to be a medical chart related to acetaminophen (a common pain reliever). The chart shows a graph with time (in hours) on the x-axis and plasma or serum acetaminophen concentration (in mcg/mL) on the y-axis. There is a dashed line indicating a threshold above which this medication is considered hepatotoxic (toxic to the liver). The text advises that if the concentration values fall above this line, hepatotoxicity is likely to occur and acetylcysteine (a medication used to treat acetaminophen overdose) should be continued.*
FDA Label Image

Package Label-principal Display Panel (6 g per 30 mL (200 mg / mL))

Package Label-principal Display Panel (6 g per 30 mL (200 mg / mL))
This is a description of Acetylcysteine Injection, a prescription only product. It is distributed by AuroMedics Pharma LLC and contains 200mg acetylcysteine USP. It is advised to consult package insert for dosage information. It must be further diluted before use and is a sterile, non-pyrogenic, Single Dose Vial. It should be stored at controlled room temperature. It is important to note that this product is preservative-free and unused portions should be discarded. This product should not be used if it has previously been opened.*
FDA Label Image

Package Label-principal Display Panel (6 g per 30 mL (200 mg / mL))

Package Label-principal Display Panel (6 g per 30 mL (200 mg / mL))
This is the description of Acetylcysteine Injection, a prescription medication used for Intravenous use. Each vial contains 200mg/mL of Acetylcysteine and 0.5g edetate disodium, which must be further diluted before usage. The medication is sterile and is available in Non-pyrogenic Single Dose Vials of 4x30mL. The usual dosage of the medication is given as per the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] and the unused portion must be discarded. It also indicates that the vial stoppers are not made with natural rubber latex. The medication is distributed by AuroMedics Pharma LLC and is made in India.*
FDA Label Image

Acetylcysteine Chemical Structure (Acetylcysteine Str)

Acetylcysteine Chemical Structure (Acetylcysteine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.